ORTHOReBIRTH USA markets ReBOSSIS, the only biosynthetic scaffold with electrospun microfiber construction designed to support cell activation, retention and proliferation. The orthobiologics company recently signed a letter of intent to develop new biologics products with neurosurgeon Loubert S. Suddaby, MD.
Adventist Health System is a faith-based healthcare system comprised of 48 hospital campuses with more than 80,000 employees.
More articles on biologics:
Innovasis enters partnership to expand into biologics market: 5 insights
FDA warns biologics company about illegally manufacturing stem cell products: 5 insights
4 things to know about CollPlant
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.